|
On april 2, 2026, the user reported discrepancies between blood glucose (bg) and sensor glucose (sg) readings.Review of available sensor data in the data management system (dms) indicated that the observed decrepancies occurred during the initial post-insertion period (early wear time), which is described in the user guide and supported by clinical performance data as an expected phase of sensor stabilization.The user was educated about this adjustment period and advised to continue using the system, entering any additional calibrations as prompted by the system.The user was informed that the system is expected to improve following stabilization.The user acknowledged this guidance and agreed to continue use of the system as instructed.
|